Anemia of chronic diseases – the key mechanisms of pathogenesis and the attempt of the classification

Written by Sakhin V.T., Kryukov E.V., Rukavitsyn O.A.

  UDK: 616.155.194–02:661–002–036.12 | DOI: 10.17238/PmJ1609-1175.2019.1.33–37  Pages: 33–37 | Full text PDF | Open PDF 


Objective: The study objective is to determine the role of cytokines, hepcidin and soluble transferrin receptor (sTfR) in anemia pathogenesis in patients with malignant neoplasms and to suggest a working version of the pathogenetic classification of anemia of chronic diseases.
Methods: 63 patients with stage II–IV of a malignant neoplasm were examined. Anemia (1st group) was diagnosed in 41 people, in 22 cases no signs of anemia were found (2nd group). A comparative analysis of the metabolism of iron, C-reactive protein (CRP), hepcidin, sTfR, as well as interleukins (IL) 6 and 10 and tumor necrosis factor α (TNFα) was performed.
Results: Patients with anemia compared with group 2 in the serum of peripheral blood showed lower levels of iron, total iron binding capacity, transferrin saturation coefficient with iron, and higher concentrations of CRP, hepcidin, sTfR, IL6, IL10 and TNFα.
Conclusions: Based on the correlation analysis, a multicomponent genesis of anemia in malignant tumors was demonstrated. A working version of the classification of anemia of chronic diseases based on the leading pathogenetic factor is proposed: 1) primary iron deficiency, 2) disruption of the regulatory mechanisms of erythropoiesis, 3) insufficient erythropoietin production.

Links to authors:

V.T. Sakhin1, E.V. Kryukov2, O.A. Rukavitsyn2
1 1586 Military hospital (4 Mashtakova St. Podolsk 142110 Russian Federation),
2 Main Military Clinical Hospital n.a. N. Burdenko (3 Gospitalnaya Sq. Moscow 105229 Russian Federation)

1. Anemia / O.A. Rukavitsin [ed.]. 2nd revised edition. Moscow: GEOTAR-Media, 2016. 256 p.
2. Hematology: National national guidelines / O.A. Rukavitsin [ed.]. Moscow: GEOTAR-Media, 2015. P. 143–149.
3. Sakhin V.T., Madjanova E.R, Kryukov E.V. Anemia of chronic diseases: Features of pathogenesis and possibilities of therapeutic correction (review of the literature and the results of our research) // Oncohematology. 2018. Vol. 13, No. 1. P. 45–53.
4. Sakhin V.T., Madjanova E.R, Kryukov E.V. [et al.]. Pathogenetic features of anemia in patients with solid tumors // Clinical Oncohematology. 2017. Vol. 10, No. 4. P. 514–519.
5. Stuklov N.I., Kozinets G.I., Tyurina N.G. Hematology Tutorial. Moscow: Practical Medicine, 2018. 336 p.
6. De Lurdes Agostinho Cabrita A., Pinho A., Malho A. [et al.]. Risk factors for high erythropoiesis stimulating agent resistance index in pre-dialysis chronic kidney disease patients, stages 4 and 5 // International Urology and Nephrology. 2011. Vol. 43. P. 835–840.
7. Ganz T., Nemeth E. Hepcidin and iron homeostasis // Biochimica et Biophysica Acta. 2012. Vol. 1823. P. 1434–1443.
8. Huang P., Wang J., Lin X. [et al.]. Effects of IL-10 on iron metabolism in LPS-induced inflammatory mice via modulating hepcidin expression // Eur. Rev. Med. Pharmacol. Sci. 2017. Vol. 21. P. 3469–3475.
9. McCranor B., Kim M., Cruz N. [et al.]. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells // Blood Cells Mol. Dis. 2014. Vol. 52. P. 126–133.
10. Park S. Iron deficient erythropoiesis might play key role in development of anemia in cancer patients // Oncotarget. 2015. Vol. 6. P. 42803–42812.
11. Poggiali E., Migone De Amicis M., Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases // EJIM. 2014. Vol. 25. P. 12–17.
12. Raj D. Role of interleukin-6 in the anemia of chronic disease // Seminars in Arthritis and Rheumatism. 2009. Vol. 38. P. 382–388.
13. Shanmugam N.K., Ellenbogen S., Trebicka E. [et al.]. Tumor necrosis factor α inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitis // PLoS One. 2012 Vol. 7. e38136. doi: 10.1371/journal.pone.0038136.
14. Steinmetz T., Totzke U., Schweigert M. [et al.]. A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry // European Journal of Cancer Care. 2011. Vol. 20, No. 4. P. 493–502.
15. Weiss G. Iron metabolism in the anemia of chronic disease // Biochimica et Biophysica Acta. 2009. Vol. 1790, No. 7. P. 682–693.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.